The RAV12 monoclonal antibody recognizes the N-linked glycotope RAAG12: expression in human normal and tumor tissues

Area of Science:

• Oncology
• Immunology
• Molecular Biology

Background:

• RAAG12 is a primate-restricted N-linked carbohydrate antigen found on membrane proteins.
• The RAV12 monoclonal antibody recognizes RAAG12 and has shown potential in targeting gastrointestinal adenocarcinomas.

Purpose of the Study:

• To profile RAAG12 expression in normal and cancerous tissues.
• To identify potential clinical applications and safety considerations for RAV12 therapy.

Main Methods:

• Immunohistochemistry was performed on 36 normal human tissues.
• A wide array of tumor tissues were analyzed to determine RAAG12 expression patterns.

Main Results:

• Over 90% of colon, gastric, and pancreatic adenocarcinomas expressed RAAG12 uniformly.
• Other cancers like esophageal, ovarian, liver, breast, and prostate carcinomas also showed RAAG12 expression, though less frequently.
• RAAG12 was detected on mucosal and glandular epithelium, with distinct subcellular localization in tumors compared to normal tissues.

Conclusions:

• High RAAG12 expression on gastrointestinal tumors supports their suitability as targets for RAV12 therapy.
• Differential subcellular localization of RAAG12 in normal epithelia may influence RAV12 accessibility and potential side effects.